Owlet, Inc.

Owlet, Inc. develops connected pediatric health devices and software for home use, centered on wearable infant monitors, a companion mobile app, and related digital services. The company sells its products in the United States and internationally through direct-to-consumer, retail, and healthcare distribution channels.

−7,3 %

50,6 %

−37,5 %

+35,4 %

1.85

1.51

— Owlet, Inc.
%
Wearable infant monitors70% FDA-cleared and internationally certified home monitoring devices for infants.
Monitoring bundles and cameras15% Combined hardware offerings such as Dream Duo and related home monitoring products.
Subscription software10% Owlet360 recurring service that provides personalized health and sleep insights.
Accessories5% Replacement and add-on items including fabric socks and travel cases.

Owlet sells primarily to parents and caregivers of infants who want home-based monitoring, sleep information, and...

  • Parents and caregiversprimary

    Buy Dream Sock, Dream Duo, and Owlet360 to monitor infant sleep and health at home.

  • Retail channel consumersprimary

    Purchase through major retailers and online marketplaces for convenience and brand trust.

  • Healthcare and medical userssecondary

    Use medically certified products in care pathways that bridge hospital and home.

  • International distributorssecondary

    Buy and distribute products in overseas markets where regulatory clearances enable sales.

  • Subscription usersemerging

    Pay monthly for Owlet360 to access personalized pediatric health and sleep insights.

Owlet is based in the United States and sells products domestically and in more than 30 countries...

  • United States is the core market and main retail base
  • International sales span more than 30 countries
  • Key markets include Canada, Australia, the UK, and the EU
  • Regulatory clearances determine where Dream Sock can be sold
  • Owlet360 is available first in English-speaking markets

Owlet’s strategy is to use its FDA-cleared and internationally certified monitoring products to build trust with...

01
Grow the connected monitoring ecosystemmedium-term

More devices and app usage increase brand loyalty and data depth.

02
Scale Owlet360 subscriptionsshort-term

Recurring revenue can improve customer lifetime value and engagement.

03
Expand internationally through regulatory clearancesmedium-term

Approvals unlock new markets and reduce reliance on the U.S. market.

04
Deepen healthcare-channel adoptionlong-term

Medical credibility can broaden use cases and support premium positioning.

Owlet depends on consumer demand, retail sell-through, and distributor performance, so inventory levels and customer...

critical

Liquidity and financing risk

The company may need additional capital to fund operations and growth.

Scope
Business continuity and strategic flexibility
Materiality
high
high

Distributor and retailer credit risk

Sales are made through intermediaries that may delay or fail to pay.

Scope
Accounts receivable and cash collections
Materiality
high
high

Channel inventory and sell-through risk

Revenue depends on retailer stocking decisions and end-demand.

Scope
Product sales and quarterly revenue volatility
Materiality
high
high

Regulatory and product clearance risk

Medical-device style products require approvals and certifications.

Scope
Dream Sock, BabySat, international expansion
Materiality
high
high

Competition from larger and non-cleared rivals

Competitors may have more capital, broader portfolios, and reach.

Scope
Pricing, distribution, and market share
Materiality
high
medium

Privacy and marketing compliance risk

Digital acquisition depends on use of customer data and ad targeting.

Scope
Customer acquisition and brand reputation
Materiality
medium
Revenue recognition for bundled hardware and software
Affects revenue timing and quarterly comparability
Sales returns, rebates, discounts, and allowances
Affects net revenue and receivables
Deferred revenue for subscriptions
Affects revenue deferral and future revenue visibility
Inventory valuation and excess stock reserves
Affects cost of revenues and gross margin
Going concern assessment
Affects liquidity analysis and financial statement interpretation

: 29/04/2026